Breast cancer screening in women with mental illness: Comparative meta-analysis of mammography uptake

British Journal of Psychiatry

Volumn 205, Issue 6, 2014, Pages 428-435

  Mitchell, Alex J ^a   Espirito Santo Pereira, Isabel ^b   Yadegarfar, Motahare ^b   Pepereke, Shingai ^b   Mugadza, Vongai ^b   Stubbs, Brendon ^c  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

^c UNIVERSITY OF GREENWICH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANXIETY; ARTICLE; BREAST CANCER; CANCER SCREENING; COMPARATIVE STUDY; CONFIDENCE INTERVAL; DEPRESSION; DISTRESS SYNDROME; FEMALE; HEALTH CARE DISPARITY; HEALTH CARE UTILIZATION; HIGH RISK PATIENT; HUMAN; MAMMOGRAPHY; MENTAL DISEASE; META ANALYSIS; MOOD DISORDER; SYSTEMATIC REVIEW; BREAST NEOPLASMS; HEALTH SERVICE; MASS SCREENING; MENTAL DISORDERS; ORGANIZATION AND MANAGEMENT; PATHOPHYSIOLOGY; PREVENTIVE HEALTH SERVICE; PROCEDURES; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY;

BREAST NEOPLASMS; FEMALE; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; MAMMOGRAPHY; MASS SCREENING; MENTAL DISORDERS; PREVENTIVE HEALTH SERVICES; PSYCHIATRIC STATUS RATING SCALES;

EID: 84916605084     PISSN: 00071250     EISSN: 14721465     Source Type: Journal    
DOI: 10.1192/bjp.bp.114.147629     Document Type: Article

References (86)

1. Thornicroft G. Physical health disparities and mental illness: the scandal of premature mortality. Br J Psychiatry 2011; 199: 441-2.
2. De Hert M, Correll CU, Bobes J, Cetkovich-Bakmas M, Cohen D, Asai I, et al. Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care. World Psychiatry 2011; 10: 52-77.
3. De Hert M, Cohen D, Bobes J, Cetkovich-Bakmas M, Leucht S, Ndetei DM, et al. Physical illness in patients with severe mental disorders. II. Barriers to care, monitoring and treatment guidelines, plus recommendations at the system and individual level. World Psychiatry 2011; 10: 138-51.
4. Rethink Mental Illness. Lethal Discrimination (http://www.rethink.org/media/810988/Rethink%20Mental%20Illness%20-%20Lethal%20Discrimination.pdf).
5. Lawrence D, Hancock KJ, Kisely S. The gap in life expectancy from preventable physical illness in psychiatric patients in Western Australia: retrospective analysis of population based registers. BMJ 2013; 346: f2539.
6. Nielsen RE, Uggerby AS, Jensen SOW, McGrath JJ. Increasing mortality gap for patients diagnosed with schizophrenia over the last three decades - a Danish nationwide study from 1980 to 2010. Schizophr Res 2013; 146: 22-7.
7. Stubbs B, De Hert M, Sepehry AA, Correll C, Mitchell A, Soundy A, et al. A meta-analysis of prevalence estimates and moderators of low bone mass in people with schizophrenia. Acta Psychiatr Scand 2014 (doi:10.1111/acps.12313).
8. Mitchell AJ, Malone D, Doebbeling CC. Quality of medical care for people with and without comorbid mental illness and substance misuse: systematic review of comparative studies. Br J Psychiatry 2009; 194: 491-9.
9. Lord O, Malone D, Mitchell AJ. Receipt of preventive medical care and medical screening for patients with mental illness: a comparative analysis. Gen Hosp Psychiatry 2010; 32: 519-43.
10. Mitchell AJ, Lawrence D. Revascularisation and mortality rates following acute coronary syndromes in people with severe mental illness: comparative meta-analysis. Br J Psychiatry 2011; 198: 434-41.
11. Aggarwal A, Pandurangi A, Smith W. Disparities in breast and cervical cancer screening in women with mental illness: a systematic literature review. Am J Prevent Med 2013; 44: 392-8.
12. O'Rourke RW, Diggs BS, Spight DH, Robinson J, Elder KA, Andrus J, et al. Psychiatric illness delays diagnosis of esophageal cancer. Dis Esophagus 2008; 21: 416-21.
13. Baillargeon J, Kuo YF, Lin YL, Raji MA, Singh A, Goodwin JS. Effect of mental disorders on diagnosis, treatment, and survival of older adults with colon cancer. J Am Geriatr Soc 2011; 59: 1268-73.
14. World Health Organization. Cancer Control: Early Detection. Knowledge Into Action. WHO Guide for Effective Programmes. WHO, 2007 (http://www.who.int/cancer/modules/en/index.html).
15. Centers for Disease Control and Prevention. Vital signs: breast cancer screening among women aged 50-74 years -United States, 2008. MMWR Morb Mortal Wkly Rep 2010; 59; 813-6.
16. Smith RA. International programs for the detection of breast cancer. Salud Publica Mex 2011; 53: 394-404.
17. US Preventive Services Task Force. Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2009; 151: 716-26.
18. Duffy SW, Tabar L, Olsen AH, Vitak B, Allgood PC, Chen THH, et al. Absolute numbers of lives saved and overdiagnosis in breast cancer screening, from a randomized trial and from the Breast Screening Programme in England. J Med Screen 2010; 17: 25-30.
19. Marmot MG, Altman DG, Cameron DA, Dewar JA, Thompson SG, Wilcox M. The benefits and harms of breast cancer screening: an independent review. Br J Cancer 2013; 108 : 2205-40.
20. Cancer Research UK. Breast Cancer Screening Benefits and Harms (http://www.cancerresearchuk.org/cancer-info/cancerstats/types/breast/screening/Benefits-and-Harms).
21. Hendrick RE, Smith RA, Rutledge JH, Smart CR. Benefit of screening mammography in women aged 40-49: a new meta-analysis of randomized controlled trials. J Natl Cancer Inst Monogr 1997; 87-92.
22. Kerlikowske K, Grady D, Ernster V. Benefit of mammography screening in women ages 40-49 years: current evidence from randomized controlled trials. Cancer 1995; 76: 1679-81.
23. Magnus MC, Ping M, Shen MM, Bourgeois J, Magnus JH. Effectiveness of mammography screening in reducing breast cancer mortality in women aged 39-49 years: a meta-analysis. J Womens Health (Larchmt) 2011; 20: 845-52.
24. Gotzsche PC, Jorgensen KJ. Screening for breast cancer with mammography. Cochrane Database Syst Rev 2013; 6: CD001877.
25. Osborn DPJ, Levy G, Nazareth I, Petersen I, Islam A, King MB. Relative risk of cardiovascular and cancer mortality in people with severe mental illness from the United Kingdom's General Practice Research Database. Arch Gen Psychiatry 2007; 64: 242-49.
26. Musuuza JS, Sherman ME, Knudsen KJ, Sweeney HA, Tyler CV, Koroukian SM. Analyzing excess mortality from cancer among individuals with mental illness. Cancer 2013; 119: 2469-76.
27. Kisely S, Crowe E, Lawrence D. Cancer-related mortality in people with mental illness. JAMA Psychiatry 2013; 70: 209-17.
28. Ji J, Sundquist K, Ning Y, Kendler KS, Sundquist J, Chen X. Incidence of cancer in patients with schizophrenia and their first-degree relatives: a population-based study in Sweden. Schizophr Bull 2013; 39: 527-36.
29. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000; 283: 2008-12.
30. Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009; 6: 1-6.
31. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (4th edn, revised) (DSM-IV-TR). APA, 2000.
32. World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders - Diagnostic Criteria for Research. WHO, 1993.
33. Sullivan SG, Glasson EJ, Hussain R, Petterson BA, Slack-Smith LM, Montgomery PD, et al. Breast cancer and the uptake of mammography screening services by women with intellectual disabilities. Prevent Med 2003; 37: 507-12.
34. Wells G, Shea B, O'Connell D, Peterson JEA. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses (http://www.ohri.ca/programs/clinical-epidemiology/oxford.asp).
35. Zhang J, Yu KF. What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. JAMA 1998; 280: 1690-1.
36. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557-60.
37. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-88.
38. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-34.
39. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994; 50: 1088-101.
40. Baumeister H, Harter M. Prevalence of mental disorders based on general population surveys. Soc Psychiatry Psychiatr Epidemiol 2007; 42: 537-46.
41. Wittchen HU, Jacobi F. Size and burden of mental disorders in Europe - a critical review and appraisal of 27 studies. Eur Neuropsychopharmacol 2005; 15: 357-76.
42. Carney CP, Jones LE. The influence of type and severity of mental illness on receipt of screening mammography. J Gen Intern Med 2006; 21: 1097-104.
43. Chochinov HM, Martens PJ, Prior HJ, Fransoo R, Burland E. Does a diagnosis of schizophrenia reduce rates of mammography screening? A Manitoba population-based study. Schizophr Res 2009; 113: 95-100.
44. Druss BG, Rosenheck RA, Desai MM, Perlin JB. Quality of preventive medical care for patients with mental disorders. Med Care 2002; 40: 129-36.
45. Lindamer LA, Buse DC, Auslander L, Unutzer J, Bartels SJ, Jeste DV. A comparison of gynecological variables and service use among older women with and without schizophrenia. Psychiatr Serv 2003; 54: 902-4.
46. Werneke U, Horn O, Maryon-Davis A, Wessely S, Donnan S, McPherson K. Uptake of screening for breast cancer in patients with mental health problems. J Epidemiol Commun Health 2006; 60: 600-5.
47. Iezzoni LI, McCarthy EP, Davis RB, Harris-David L, O'Day B. Use of screening and preventive services among women with disabilities. Am J Med Qual 2001; 16: 135-44.
48. Druss BG, Rask K, Katon WJ. Major depression, depression treatment and quality of primary medical care. Gen Hosp Psychiatry 2008; 30: 20-5.
49. Green CA, Pope CR. Depressive symptoms, health promotion, and health risk behaviors. Am J Health Promot 2000; 15: 29-34.
50. Patten SB, Williams JVA, Lavorato DH, Eliasziw M. The effect of major depression on participation in preventive health care activities. BMC Public Health 2009; 9: 87.
51. Peytremann-Bridevaux I, Voellinger R, Santos-Eggimann B. Healthcare and preventive services utilization of elderly Europeans with depressive symptoms. J Affect Disord 2008; 105: 247-52.
52. Pirraglia PA, Sanyal P, Singer DE, Ferris TG. Depressive symptom burden as a barrier to screening for breast and cervical cancers. J Womens Health (Larchmt) 2004; 13: 731-8.
53. Stecker T, Fortney JC, Prajapati S. How depression influences the receipt of primary care services among women: a propensity score analysis. J Womens Health (Larchmt) 2007; 16: 198-205.
54. Masterson EA, Hopenhayn C, Christian WJ. Self-reported mental health status and recent mammography screening. J Womens Health (Larchmt) 2010; 19: 1569-76.
55. Ludman EJ, Ichikawa LE, Simon GE, Rohde P, Arterburn D, Operskalski BH, et al. Breast and cervical cancer screening: specific effects of depression and obesity. Am J Prevent Med 2010; 38: 303-10.
56. Vigod S, Kurdyak P, Stewart D, Gnam W, Goering P. Depressive symptoms as a determinant of breast and cervical cancer screening in women: a population-based study in Ontario, Canada. Arch Womens Ment Health 2011; 14: 159-68.
57. Aggarwal A, Freund K, Sato A, Adams-Campbell LL, Lopez AM, Lessin LS, et al. Are depressive symptoms associated with cancer screening and cancer stage at diagnosis among postmenopausal women? The Women's Health Initiative observational cohort. J Womens Health (Larchmt) 2008; 17: 1353-61.
58. Blackwell DL, Martinez ME, Gentleman JF. Women's compliance with public health guidelines for mammograms and Pap tests in Canada and the United States: an analysis of data from the Joint Canada/United States Survey of Health. Womens Health Issues 2008; 18: 85-99.
59. Kempe KL, Larson RS, Shetterley S, Wilkinson A. Breast cancer screening in an insured population: whom are we missing? Perm J 2013; 17: 38-44.
60. Schwartz MD, Taylor KL, Willard KS. Prospective association between distress and mammography utilization among women with a family history of breast cancer. J Behav Med 2003; 26: 105.
61. Thorpe JM, Kalinowski CT, Patterson ME, Sleath BL. Psychological distress as a barrier to preventive care in community-dwelling elderly in the United States. Med Care 2006; 44: 187-91.
62. Leiferman JA, Pheley AM. The effect of mental distress on women's preventive health behaviors. Am J Health Promot 2006; 20: 196-9.
63. Lasser KE, Zeytinoglu H, Miller E, Becker AE, Hermann RC, Bor DH. Do women who screen positive for mental disorders in primary care have lower mammography rates? Gen Hosp Psychiatry 2003; 25: 214-6.
64. Yee EFT, White R, Lee SJ, Washington DL, Yano EM, Murata G, et al. Mental illness: is there an association with cancer screening among women veterans? Womens Health Issues 2011; 21: S195-202.
65. Koroukian SM, Bakaki PM, Golchin N, Tyler C, Loue S. Mental illness and use of screening mammography among Medicaid beneficiaries. Am J Prevent Med 2012; 42: 606-9.
66. Health and Social Care Information Centre. Breast Cancer Screening Program in England. HSCIC, 2013 (http://www.hscic.gov.uk/catalogue/PUB10339).
67. Perini G, Grigoletti L, Hanife B, Biggeri A, Tansella M, Amaddeo F. Cancer mortality among psychiatric patients treated in a community-based system of care: a 25-year case register study. Soc Psychiatry Psychiatr Epidemiol 2014; 49: 693-701.
68. Osborn DP, Baio G, Walters K, Petersen I, Limburg H, Raine R, et al. Inequalities in the provision of cardiovascular screening to people with severe mental illnesses in primary care: cohort study in the United Kingdom THIN Primary Care Database 2000-2007. Schizophr Res 2011; 129: 104-10.
69. Roberts L, Roalfe A, Wilson S, Lester H. Physical health care of patients with schizophrenia in primary care: a comparative study. Family Pract 2007; 24: 34-40.
70. Mitchell AJ, Hardy SA. Screening for metabolic risk among patients with severe mental illness and diabetes: a national comparison. Psychiatr Serv 2013; 64: 1060-3.
71. Mitchell AJ, Lord O, Malone D. Differences in the prescribing of medication for physical disorders in individuals with v. without mental illness: metaanalysis. Br J Psychiatry 2012; 201: 435-43.
72. Ng DM, Jeffery RW. Relationships between perceived stress and health behaviors in a sample of working adults. Health Psychol 2003; 22: 638-42.
73. O'Donnell S, Goldstein B, DiMatteo MR, Fox SA, John CR, Obrzut JE. Adherence to mammography and colorectal cancer screening in women 50-80 years of age: the role of psychological distress. Womens Health Iss 2010; 20: 343-9.
74. Kotwal AA, Schumm P, Mohile SG, Dale W. The influence of stress, depression, and anxiety on PSA screening rates in a nationally representative sample. Med Care 2012; 50: 1037-44.
75. Consedine NS, Morgenstern AH, Kudadjie-Gyamfi E, Magai C, Neugut AI. Prostate cancer screening behavior in men from seven ethnic groups: the fear factor. Cancer Epidemiol Biomarkers Prev 2006; 15: 228-37.
76. Hardy S, Gray R. Is the use of an invitation letter effective in prompting patients with severe mental illness to attend a primary care physical health check? Prim Health Care Res Dev 2012; 13: 347-52.
77. Kahn LS, Fox CH, Krause-Kelly J, Berdine DE, Cadzow RB. Identifying barriers and facilitating factors to improve screening mammography rates in women diagnosed with mental illness and substance use disorders. Women Health 2005; 42: 111-26.
78. Mitchell AJ, Selmes T. Why don't patients attend their appointments? Maintaining engagement with psychiatric services. Adv Psychiatr Treatment 2007; 13: 423-34.
79. Legg JS, Clement DG, White KR. Are women with self-reported cognitive limitation at risk for underutilization of mammography? J Health Care Poor Underserved. 2004; 15: 688-702.
80. Temitope B, Daniel A, Ademola A. A survey of physicians' attitudes and practices to screening mammography in Osogbo & Ibadan, South-West Nigeria. Internet Journal of Radiology 2006; 6: 1.
81. Miller E, Lasser KE, Becker AE. Breast and cervical cancer screening for women with mental illness: patient and provider perspectives on improving linkages between primary care and mental health. Arch Womens Ment Health 2007; 10: 189-97.
82. Friedman LC, Puryear LJ, Moore A, Green CE. Breast and colorectal cancer screening among low-income women with psychiatric disorders. Psychooncology 2005; 14: 786-91.
83. Starfield B, Leiyu S, Macinko J. Contribution of primary care to health systems and health. Milbank Q 2005; 83: 457-502.
84. Lester HE, Soroham H, Tritter JQ. Patients' and health professionals' views on primary care for people with serious mental illness: focus group study. BMJ 2005; 330: 1122-6.
85. Jorgensen KJ, Gotzsche PC. Overdiagnosis in publicly organised mammography screening programmes: systematic review of incidence trends. BMJ 2009; 339: b2587.
86. Miller AB, Wall C, Baines CJ, Sun P, To T, Narod SA. Twenty five year followup for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial. BMJ 2014; 348: g366.